Efficacy of supervised tabata protocol on endocrine-metabolic disorder of stressed Overweight Polycystic Ovary Syndrome Female in Pakistan

Main Article Content

zainab Razzaq Muhammad Ali shah DUHS Shazia khan CMH quetta

Keywords

Tabata exercise, insulin resistance, body composition, lipid profile and polycystic ovary syndrome

Abstract

As the life expectancy increases, 20 % of women spend second decade of their life along with polycystic ovary syndrome where an alteration in the hormonal levels specially androgen hormone are documented leading to hallmark in  increase in  insulin resistance leading metabolic-endocrine disorder. The prevalence of PCOS in our country is unavoidable and suffering women struggle to survive in society. Hence this study is aiming to provide evidence-based results on the effectiveness of tabata training on symptoms of PCOS

Abstract 137 | pdf Downloads 31

References

1. Anjum S, Askari S, Riaz M, et al. (December 02, 2020) Clinical Presentation and Frequency of Metabolic Syndrome in Women with Polycystic Ovary Syndrome: An Experience from a Tertiary Care Hospital in Pakistan. Cureus 12(12): e11860.
2. Nasira Munawar Lone, Sana Babar, Sikandar Sultan, Saira Malik, Kiran Nazeer & Saba Riaz (2021) Association of the CYP17 and CYP19 gene polymorphisms in women with polycystic ovary syndrome from Punjab, Pakistan, Gynecological Endocrinology, 37:5, 456-461,
3. Rizvi M, Islam MA, Aftab MT, Naqvi AA, Jahangir A, Ishaqui AA, et al. (2023) Knowledge, attitude, and perceptions about polycystic ovarian syndrome, and its determinants among Pakistani undergraduate students. Plos ONE 18(5): e0285284.
4. Zulfiqar, S. ., Tahir, S. ., Gulraiz, S. ., Razzaq, M. A. ., Abid, A. ., Shahid, T. ., Babar, A., Rehman, B. ., Rafique, H. ., Noor, S. ., & Anjum, I. . (2022). Investigation of Prevalence and Awareness of Polycystic Ovary Syndrome among Pakistani Females: Polycystic Ovary Syndrome in Pakistani Women. Proceedings of the Pakistan Academy of Sciences: B. Life and Environmental Sciences, 59(1), 77–83
5. Tahir, F. N., Kanwal, S., Safdar, M., Malik, A. A., Hakim, S., & Ashraf, M. N. (2023, April 29). Polycystic Ovaries and Associated Clinical and Biochemical Features in Young Women. Pakistan Journal of Medical and Health Sciences.
6. Hira Javed, Sadia Niazi, Adnan Adil, Anam Yousaf, Anam Khan, Saba Ghayas. Body image concern as mediator between obesity and sexual satisfaction: a comparative study of married women with and without polycystic ovarian syndrome. Rawal Medical Journal: Vol. 47, No. 2, Apr-Jun 2022.
7. SIDRA, S., TARIQ, M. H., FARRUKH, M. J. & MOHSIN, M. 2019. Evaluation of clinical manifestations, health risks, and quality of life among women with polycystic ovary syndrome. Plos One, 14, e0223329.
8. ORBETZOVA, M. M. 2020. Clinical Impact of Insulin Resistance in Women with Polycystic Ovary Syndrome. Polycystic Ovarian Syndrome. Intech Open
9. Hellas Cena and others, Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists, The Journal of Clinical Endocrinology & Metabolism, Volume 105, Issue 8, August 2020, Pages e2695–e2709,
10. Yuanyuan Guan, Dongjun Wang, Huaien Bu, Tieniu Zhao, and Hongwu Wang. The Effect of Metformin on Polycystic Ovary Syndrome in Overweight Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Hindawi. International Journal of Endocrinology.2020; 5150684, 12.
11. Somayeh baharloo, n. S., khosro ebrahim, fahimeh raazmezani tehrani, zahra allameh 2021. The effect of 12 weeks water-based tabata training on insulin resistance, apolipoprotein and apolipoprotein b in obese women with polycystic ovary syndrome. Razi journal medical sciences, 28.
12. Thomas M Barber, Petra Hanson, Martin O Weickert, Stephen Franks. Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies. Sage journals. Clinical Medicine Insights: Reproductive Health. 2019; 13: 1–9.
13. Zeng, Xin, Xie, Yuan, Liu, Ya, Long, Shuang, and Zhong Mo. "Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity." Clinical Chemical Acta. 2020; 502. 214-221.
14. Saadia, Zaheera. "Follicle Stimulating Hormone (LH: FSH) Ratio in Polycystic Ovary Syndrome (PCOS) - Obese vs. Non- Obese Women." Medical Archives. 2020; 74, 4, 289-293.
15. Huang, X., Wang, Q., Liu, T. et al. Body fat indices as effective predictors of insulin resistance in obese/non-obese polycystic ovary syndrome women in the Southwest of China. Endocrine. 2019; 65, 81–85.
16. Lie Fong, Sharon, Douma, Annewiets, and Johan Verhaeghe. "Implementing the international evidence-based guideline of assessment and management of polycystic ovary syndrome (PCOS): how to achieve weight loss in overweight and obese women with PCOS?" Journal of Gynecology Obstetrics and Human Reproduction 2021; 50, 6, 101894.
17. Yu, Jin, Zhou, Yulai, Ding, Jie, Zhang, Danying, Yu, Chaoqin, and Hefeng Huang. "Characteristics and possible mechanisms of metabolic disorder in overweight women with polycystic ovary syndrome." Frontiers in Endocrinology. 2023; 13, 970733.
18. Neubronner, S.A., Indran, I.R., Chan, Y.H. et al. Effect of body mass index (BMI) on phenotypic features of polycystic ovary syndrome (PCOS) in Singapore women: a prospective cross-sectional study. BMC Women's Health.2021; 21, 135.
19. Yang, Szu, Liu, Chia, Ma, Sheng, Chang, Wen, Chen, Yi, Lee, Wen, and Peng Wang. "Association between Pre-Pregnancy Overweightness/Obesity and Pregnancy Outcomes in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis." International Journal of Environmental Research and Public Health.2022; 19, 15.